Bonert Michael, Zafar Uzma, Williams Phillip, El-Shinnawy Ihab, Juergens Rosalyn A, Naqvi Asghar, Cutz Jean-Claude, Finley Christian, Major Pierre, Kapoor Anil
Pathology and Molecular Medicine, Division of Anatomical Pathology, McMaster University, Hamilton, CAN.
Pathology, Monmouth Medical Center, Long Branch, USA.
Cureus. 2022 Aug 5;14(8):e27714. doi: 10.7759/cureus.27714. eCollection 2022 Aug.
Background Ineffective communication between healthcare providers is a known risk factor for adverse events. Objective The aim of this study was to retrospectively assess the communication with pathology via an analysis of the information provided on the pathology requisitions over ten years. Methods All in-house surgical specimens and all non-gynecologic cytopathology specimens accessioned from 2011 to 2020 were retrieved at a regional laboratory. Cases with any clinical information were deemed to have a clinical history present (CHP). CHP was tabulated by submitting physicians/surgeons (SPS), hospital site, year, and tissue group. Results The study period contained 554,817 relevant pathology reports, of which 553,966 could be extracted. The overall CHP rate was 74% and varied from 76% to 67% over the study period. SPSes submitting ≥200 cases (n=314) had a mean/median/standard deviation/max/min CHP rate of 81%/92%/23%/100%/5%. The CHP varied between four hospital sites, from 53% to 97%. CHP varied from 61% to 99% by tissue group. Conclusions CHP is associated with several factors and appears to depend on the hospital culture, specialty, and individual physician/surgeon. The pathology requisition is a way to measure and track the communication that is clinically relevant. Improving communication with pathologists/the pathology department will likely require process changes and mandates. Hospital and laboratory accreditation bodies should consider effective communication with pathology a marker of quality and an accreditation issue.
医疗服务提供者之间沟通不畅是不良事件的已知风险因素。目的：本研究旨在通过分析十年间病理检查申请单上提供的信息，对与病理科的沟通进行回顾性评估。方法：在一个区域实验室检索了2011年至2020年接收的所有内部手术标本和所有非妇科细胞病理学标本。有任何临床信息的病例被视为有临床病史（CHP）。CHP按提交医生/外科医生（SPS）、医院地点、年份和组织类型进行列表统计。结果：研究期间有554,817份相关病理报告，其中553,966份可以提取。总体CHP率为74%，在研究期间从76%到67%不等。提交≥200例病例的SPS（n = 314）的平均/中位数/标准差/最高/最低CHP率为81%/92%/23%/100%/5%。CHP在四个医院地点之间有所不同，从53%到97%。CHP按组织类型从61%到99%不等。结论：CHP与多个因素相关，似乎取决于医院文化、专业和个体医生/外科医生。病理检查申请单是衡量和跟踪临床相关沟通的一种方式。改善与病理学家/病理科的沟通可能需要流程改变和强制要求。医院和实验室认证机构应将与病理科的有效沟通视为质量标志和认证问题。
